Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
Filing tables
Filing exhibits
- 10-K Annual report
- 21.1 List of Subsidiaries
- 23.1 Consent of Kesselman & Kesselman, Certified Public Accountant (Isr.), Independent Registered Public Accounting Firm, a Member of Pricewaterhousecoopers International Limited
- 31.1 Certification
- 31.2 Certifications
- 32.1 Certifications
- 32.2 Certifications
- Download Excel data file
- View Excel data file
Indaptus Therapeutics similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-1 (No. 333-238973), Form S-3 (No. 333-230016) and Form S-8 (No. 333-227027, No. 333-222217, No. 333-209700, No. 333-212801 and No. 333-248073) of Intec Pharma Ltd. of our report dated March 15, 2021 relating to the financial statements, which appears in this Form 10-K.
Tel-Aviv, Israel | /s/ Kesselman & Kesselman |
March 16, 2021 | Certified Public Accountants (Isr.) |
A member firm of PricewaterhouseCoopers International Limited |
Kesselman & Kesselman, 146 Derech Menachem Begin, Tel-Aviv 6492103, Israel,
P.O Box 7187 Tel-Aviv 6107120, Telephone: +972 -3- 7954555, Fax:+972 -3- 7954556, www.pwc.com/il